Marlborough

Bedford-based Hologic, Inc. which has operations in Marlborough, announced it has named Stephen P. MacMillan as its new president and CEO.

A Malden investor has purchased the Marlborough Village Plaza for $5.68 million.

A newly-formed explosion protection company has signed a lease for 32,400 square feet of office space in a revamped Marlborough building.

Oxford Immunotec Global PLC, a medical diagnostic company with U.S. headquarters in Marlborough, has raised $62.8 million through an initial public offering of stock that closed Monday.

Jon Delli Priscoli looked to Cambridge for inspiration as he sought to make his mark in MetroWest.The...

Natick-based Boston Scientific Corp. has received approval from the U.S. Food and Drug Administration (FDA) on its new stent system designed to treat coronary heart disease.

Advanced Cell Technology of Marlborough reported another quarterly loss as it continued testing for a vision-treatment drug and applied for federal approval of another drug that could potentially treat both humans and animals.

The U.S. Food and Drug Administration has approved a new drug made by Sunovion Pharmaceuticals to reduce seizures associated with epilepsy.

State officials agreed this week to fund $1.6 million of infrastructure upgrades as part of the redevelopment of the former Hewlett Packard complex in Marlborough, according to the Marlborough Economic Development Corporation.

Boston Biomedical Associates (BBA) had just five employees in a single Northborough suite when it launched in 1999. As the biomedical consulting industry grew, BBA expanded its headcount to 52. Those employees worked out of five suites scattered throughout an office building, making it difficult to coordinate across departments, said Mack Rubley, the company's director of business development.